Learn About Central Serous Chorioretinopathy

What is the definition of Central Serous Chorioretinopathy?
Central serous chorioretinopathy is a disease that causes fluid to build up under the retina, the back part of the inner eye that sends sight information to the brain. The fluid leaks from the choroid (the blood vessel layer under the retina). The cause of this condition is unknown but stress can be a risk factor. Signs and symptoms include dim and blurred blind spot in the center of vision, distortion of straight lines and seeing objects as smaller or farther away.
Save information for later
Sign Up
What are the alternative names for Central Serous Chorioretinopathy?
  • Central serous chorioretinopathy
  • Central serous chorioretinopathy after bone marrow transplantation
  • Central serous choroidopathy
Who are the top Central Serous Chorioretinopathy Local Doctors?
Elite
Elite
 
 
 
 
Learn about our expert tiers
Learn more
Elite
What are the latest Central Serous Chorioretinopathy Clinical Trials?
Steroid Eye Drops Versus Placebo Eye Drops in Chronic Central Serous Chorioretinopathy Trial (PICS Trial)

Summary: In this pilot study the effect and safety of the use of steroid eye drops in chronic central serous chorioretinopathy (cCSC) will be evaluated. The study is conducted as a randomized single-blind placebo-controlled trial. Forty patients will be randomized to either steroid eye drops or placebo eye drops. Patients will self-administer the eye drops three times a day for four weeks.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Choroidal Blood Flow in Acute and Chronic Central Serous Chorioretinopathy

Summary: Patients with central serous chorioretinopathy (CSC) will be monitored with laser speckle flow graphy (LSFG), swept source optical coherence tomography (SS-OCT) and SS-OCT angiography (SS-OCTA). We aim to unveil the flow and pulse wave characteristics of the choroidal circulation in acute CSC and chronic CSC.

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Central Serous Chorioretinopathy?
Central Serous Chorioretinopathy in a 14-year-old atopic boy: a case report.
Topical Dexamethasone as an Adjuvant to Mineralocorticoid Receptor Antagonists for the Treatment of Recalcitrant Central Serous Chorioretinopathy.
Tired of the same old research?
Check Latest Advances
Ocular toxicity of targeted therapies with MEK inhibitors and BRAF inhibitors in the treatment of metastatic cutaneous melanoma.